News, reviews and podcasts from annual scientific meetings and symposiums around the world.
ASH 2021: Bispecific antibody mosunetuzumab brings deep remission for follicular lymphoma
A phase I/II trial for the experimental drug mosunetuzumab met its primary endpoint, leading to…